Key result
caFFR-concordant LAD lesions are linked to ~49% higher vessel-oriented composite events versus non-LAD lesions.
Why the study?
Whether physiological guidance using caFFR-concordant treatment fully mitigates the inherent prognostic disadvantage of LAD artery lesions in stable ischaemic heart disease remains incompletely understood.
Does caFFR-concordant revascularisation or deferral mitigate the excess risk of vessel-oriented cardiovascular events in left anterior descending (LAD) artery lesions compared to non-LAD lesions in patients with stable ischaemic heart disease?
Cohort (n=1,679)
Does caFFR-concordant revascularisation or deferral mitigate the excess risk of vessel-oriented cardiovascular events in left anterior descending (LAD) artery lesions compared to non-LAD lesions in patients with stable ischaemic heart disease?
Even when revascularisation decisions are concordant with angiography-derived fractional flow reserve (caFFR), LAD lesions confer a significantly higher long-term risk of vessel-oriented events and myocardial infarction than non-LAD lesions, particularly among ischaemic vessels.
Persistent excess risk in caFFR-concordant LAD lesions warrants caution; leaves open whether LAD-specific thresholds or adjunctive strategies are needed.
Background Current guidelines advocate physiology-guided revascularisation in stable ischaemic heart disease (SIHD), with the expectation that functional optimisation may standardise outcomes across coronary territories. Computational pressure-flow dynamics-derived fractional flow reserve (caFFR) is an angiography-derived index that determines FFR without invasive pressure wire or hyperaemic stimulus. However, whether physiological guidance fully accounts for the inherent risk associated with left anterior descending (LAD) artery lesions remains incompletely understood. Purpose To determine whether caFFR-concordant treatment mitigates the established prognostic disadvantage of LAD lesions in SIHD. Methods In this retrospective cohort study of 1679 SIHD patients, caFFR was analysed in 5037 vessels. Patients underwent revascularization at the discretion of the proceduralist according to the angiographic and clinical data available at the time. Treatment decisions were classified by concordance with caFFR (revascularisation for caFFR ≤0.80; deferral for >0.80). The primary endpoint was the vessel-oriented composite endpoint, defined as vessel-related cardiovascular mortality, myocardial infarction (MI) and unplanned revascularisation at median 4.4-year follow-up. Results Among 3500 analysable vessels, 2720 (77.7%) were treated concordantly with caFFR, with 827 (30.4%) LAD and 1893 (69.6%) non-LAD vessels. Despite physiology-concordant management, LAD lesions demonstrated significantly higher event rates than non-LAD lesions (VOCE: 7.1% vs 4.8%, P=0.014; MI: 1.9% vs 0.8%, P=0.010). In multivariable analysis, concordantly managed LAD lesions remained independently associated with increased risk of VOCE (HR 1.49; 95% CI 1.08-2.07; P=0.016) and MI (HR 2.46; 95% CI 1.21-4.97; P=0.012). Notably, significant interaction was observed between LAD territory and ischaemic status (P-interaction=0.040): ischaemic LAD lesions (caFFR ≤0.80) exhibited heightened risk (HR 1.79; 95% CI 1.13–2.83), whereas non-ischaemic LAD lesions showed no excess risk (HR 0.90; 95% CI 0.56–1.46). Conclusion Even when revascularisation decisions are concordant with caFFR, LAD lesions continue to confer higher long-term risk of vessel-oriented events and myocardial infarction compared with non-LAD lesions. These findings suggest that physiological guidance, while essential, may benefit from integration with anatomical and vessel-specific considerations. Comprehensive risk stratification incorporating both functional assessment and coronary territory may further optimize decision-making in LAD disease.
No takes yet. Share an insight, caveat, or question.
Sze et al. (2026) conducted a cohort in Stable ischaemic heart disease (SIHD) (n=1,679). caFFR-concordant left anterior descending (LAD) artery lesions vs. caFFR-concordant non-LAD lesions was evaluated on Vessel-oriented composite endpoint (VOCE: vessel-related cardiovascular mortality, myocardial infarction, and unplanned revascularisation) (HR 1.49, 95% CI 1.08-2.07, p=0.016). caFFR-concordant LAD lesions had higher vessel-oriented composite events than non-LAD lesions (7.1% vs 4.8%; HR 1.49; 95% CI 1.08-2.07; P=0.016).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: